|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.30 USD | -1.02% |
|
-4.96% | +30.95% |
| 07-29 | Deutsche Bank Adjusts CVS Health Price Target to $116 From $92 | MT |
| 07-29 | X, World Federation of Advertisers settle litigation over GARM dispute | RE |
| Market Cap | 134B 117B 109B 100B 189B 12,815B 192B 1,286B 504B 6,390B 505B 494B 21,078B | P/E 2026 * |
16.7x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 190B 165B 154B 142B 267B 18,130B 272B 1,820B 713B 9,041B 714B 699B 29,821B | EV / Sales 2026 * |
0.46x | EV / Sales 2027 * | 0.44x |
| Free-Float |
71.2% | Yield 2026 * |
2.52% | Yield 2027 * | 2.6% |
Last Transcript: CVS Health Corporation
| 1 day | -0.99% | ||
| 1 week | -4.96% | ||
| Current month | -0.49% | ||
| 1 month | +1.80% | ||
| 3 months | +26.72% | ||
| 6 months | +38.12% | ||
| Current year | +30.95% |
| 1 week | 103.01 |  | 110 |
| 1 month | 101.78 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 61.35 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.02% | -4.96% | +69.11% | +42.57% | 134B | |
| -2.28% | -4.41% | +10.06% | +48.77% | 88.03B | |
| -0.97% | +0.47% | +7.28% | +58.68% | 29.01B | |
| +0.16% | -1.75% | +34.42% | +70.88% | 25.6B | |
| +0.38% | +0.76% | -8.26% | -16.41% | 22.18B | |
| -0.36% | -5.06% | +54.81% | +234.79% | 20.13B | |
| -1.59% | -4.18% | +64.45% | +110.86% | 15B | |
| -0.06% | -0.64% | +2.71% | -2.26% | 14.73B | |
| -8.95% | -5.15% | -5.24% | -12.76% | 13.68B | |
| -1.93% | -3.24% | -14.50% | +98.29% | 11.13B | |
| Average | -1.63% | +0.98% | +21.48% | +63.34% | 37.39B | |
| Weighted average by Cap. | -1.39% | +0.89% | +34.67% | +54.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 356B 332B 305B 575B 39,030B 585B 3,918B 1,534B 19,464B 1,538B 1,504B 64,198B | 427B 371B 346B 318B 599B 40,655B 610B 4,081B 1,598B 20,274B 1,602B 1,567B 66,870B |
| Net income | 8.1B 7.04B 6.57B 6.03B 11.38B 772B 11.58B 77.51B 30.36B 385B 30.43B 29.76B 1,270B | 9.29B 8.07B 7.54B 6.92B 13.05B 885B 13.27B 88.87B 34.81B 442B 34.89B 34.12B 1,456B |
| Net Debt | 55.76B 48.46B 45.25B 41.54B 78.32B 5,315B 79.69B 534B 209B 2,651B 209B 205B 8,743B | 52.15B 45.32B 42.31B 38.85B 73.25B 4,971B 74.52B 499B 195B 2,479B 196B 192B 8,176B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | US$104.04 | -1.26% | 848,498 |
| 26-08-03 | US$105.37 | +0.90% | 5,377,252 |
| 26-07-31 | US$104.43 | -0.75% | 7,081,286 |
| 26-07-30 | US$105.22 | -0.66% | 7,738,249 |
| 26-07-29 | US$105.92 | -3.13% | 7,718,243 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
